Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ETNew detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups ...
Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...
1 Day TEVA 1.97% DJIA 0.02% S&P 500 0.24% Health Care/Life Sciences 0.00% ...
Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone.
After hours: February 21 at 7:59:00 PM EST ...
After hours: 7:55:40 p.m. EST Loading Chart for TEVA ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
A MAJOR road on the approach to the Mersey Gateway bridge Runcorn remains is closed after a lorry crashed and overturned. The crash happened on the northbound carriage of the Weston Point Expressway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results